About
About SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Visit company website
5 years, 5 months ago
SomnoMed Limited is currently in a long term uptrend where the price is trading 14.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
SomnoMed Limited's total revenue sank by 7.3% to $31M since the same quarter in the previous year.
Its net income has dropped by 35.9% to $492K since the same quarter in the previous year.
Finally, its free cash flow grew by 259.4% to $1M since the same quarter in the previous year.
Based on the above factors, SomnoMed Limited gets an overall score of 3/5.